These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 345906)

  • 1. Management of household contacts of leprosy patients.
    Filice GA; Fraser DW
    Ann Intern Med; 1978 Apr; 88(4):538-42. PubMed ID: 345906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectivity of secondary dapsone-resistant cases.
    Jesudasan K; Pannikar V; Christian M
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):418-21. PubMed ID: 3047282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG vaccine and leprosy household contacts: Protective effect and probability to becoming sick during follow-up.
    Gomes RR; Antunes DE; Dos Santos DF; Sabino EFP; Oliveira DB; Goulart IMB
    Vaccine; 2019 Oct; 37(43):6510-6517. PubMed ID: 31500969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprophylaxis among contacts of non-lepromatous leprosy.
    Noordeen SK; Neelan PN
    Lepr India; 1976 Oct; 48(4 Suppl):635-42. PubMed ID: 800232
    [No Abstract]   [Full Text] [Related]  

  • 5. Long term effects of chemoprophylaxis among contacts of lepromatous cases. Results of 8 1/2 years follow-up.
    Noordeen SK
    Lepr India; 1977 Oct; 49(4):504-9. PubMed ID: 342824
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemoprophylaxis in leprosy.
    Br Med J; 1966 May; 1(5498):1252. PubMed ID: 5328408
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy.
    Menzel S; Harboe M; Bergsvik H; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):617-25. PubMed ID: 3323365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
    Chaudhury S; Hazra SK; Saha B; Mazumder B; Biswas PC; Chattopadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence rates of leprosy among household contacts of "primary cases".
    Jesudasan K; Bradley D; Smith PG; Christian M
    Indian J Lepr; 1984; 56(3):600-14. PubMed ID: 6549329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on prevention of leprosy. 2. Chemo-prophylaxis trial for leprosy household contact children].
    Saikawa K
    Nihon Rai Gakkai Zasshi; 1985; 54(4):187-92. PubMed ID: 3842969
    [No Abstract]   [Full Text] [Related]  

  • 11. [Leprosy: control of household contacts in the municipality of Londrina-PR for a ten-year period].
    Dessunti EM; Soubhia Z; Alves E; Aranda CM; Barro MP
    Rev Bras Enferm; 2008; 61 Spec No():689-93. PubMed ID: 19009109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years.
    Sharma P; Mukherjee R; Talwar GP; Sarathchandra KG; Walia R; Parida SK; Pandey RM; Rani R; Kar H; Mukherjee A; Katoch K; Benara SK; Singh T; Singh P
    Lepr Rev; 2005 Jun; 76(2):127-43. PubMed ID: 16038246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of lepromin positivity and immunoprophylaxis in household contacts of multibacillary leprosy patients: a pilot study with a candidate vaccine, Mycobacterium w.
    Sharma P; Kar HK; Kaur H; Misra RS; Mukherjee A; Mukherjee R; Rani R
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):136-42. PubMed ID: 11036493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh.
    Richardus RA; Butlin CR; Alam K; Kundu K; Geluk A; Richardus JH
    Vaccine; 2015 Mar; 33(13):1562-7. PubMed ID: 25701674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient contact is the major determinant in incident leprosy: implications for future control.
    van Beers SM; Hatta M; Klatser PR
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):119-28. PubMed ID: 10472363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of a trial of dapsone vs placebo in lepromatous leprosy.
    Levy L; Murray LP
    Int J Lepr Other Mycobact Dis; 1967; 35(3):393-4. PubMed ID: 4917111
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular, immunological and neurophysiological evaluations for early diagnosis of neural impairment in seropositive leprosy household contacts.
    Santos DFD; Mendonça MR; Antunes DE; Sabino EFP; Pereira RC; Goulart LR; Goulart IMB
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006494. PubMed ID: 29782495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-benefit assessment of Bacillus Calmette-Guérin vaccination, anti-phenolic glycolipid I serology, and Mitsuda test response: 10-year follow-up of household contacts of leprosy patients.
    Araujo S; Rezende MM; Sousa DC; Rosa MR; Santos DC; Goulart LR; Goulart IM
    Rev Soc Bras Med Trop; 2015; 48(6):739-45. PubMed ID: 26676499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and early detection of leprosy in children.
    Dayal R; Bharadwaj VP
    J Trop Pediatr; 1995 Jun; 41(3):132-8. PubMed ID: 7636930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.